System1, Inc. Income Taxes Disclosure
For the Year Ended | |||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||
Domestic | $ | (78,167) | $ | (92,190) | |||||||
Foreign | (5,901) | (5,478) | |||||||||
Loss before income tax | $ | (84,068) | $ | (97,668) | |||||||
For the Year Ended | |||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||
Current: | |||||||||||
Federal | $ | 35 | $ | 145 | |||||||
State | 35 | 291 | |||||||||
Foreign | (755) | 1,297 | |||||||||
Total current (benefit) provision | $ | (685) | $ | 1,733 | |||||||
Deferred: | |||||||||||
Foreign | $ | (2,190) | $ | (2,103) | |||||||
Total deferred benefit | (2,190) | (2,103) | |||||||||
Income tax benefit | $ | (2,875) | $ | (370) | |||||||
For the Year Ended | |||||||||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||||||||
Amount | % | Amount | % | ||||||||||||||
Expected income tax benefit at statutory tax rate | $ | (17,654) | 21.0 | % | $ | (20,510) | 21.0 | % | |||||||||
State tax, net of federal tax benefit | 35 | — | % | 189 | -0.2 | % | |||||||||||
Foreign tax effects | (1,258) | 1.5 | % | (104) | 0.1 | % | |||||||||||
Effects of cross-border tax laws | 709 | -0.8 | % | (162) | 0.2 | % | |||||||||||
Tax credits: | |||||||||||||||||
Research and development credits | (1,012) | 1.2 | % | (830) | 0.8 | % | |||||||||||
Other | 873 | -1.0 | % | 75 | -0.1 | % | |||||||||||
Change in valuation allowance | 6,278 | -7.5 | % | 15,496 | -15.9 | % | |||||||||||
Nontaxable or nondeductible items: | |||||||||||||||||
Stock-based compensation | 1,082 | -1.3 | % | 1,954 | -2.0 | % | |||||||||||
Non-Controlling interest | 3,710 | -4.4 | % | 6,661 | -6.8 | % | |||||||||||
Investment in partnership basis adjustments | 6,954 | -8.3 | % | (4,375) | 4.5 | % | |||||||||||
Liability reversal | (1,103) | 1.3 | % | — | — | ||||||||||||
Other nondeductibles | 56 | -0.1 | % | (190) | 0.2 | % | |||||||||||
Changes in unrecognized tax benefits | 828 | -1.0 | % | 754 | -0.8 | % | |||||||||||
Other adjustments | (2,373) | 2.8 | % | 672 | -0.7 | % | |||||||||||
Income tax benefit and effective income tax rate | $ | (2,875) | 3.4 | % | $ | (370) | 0.4 | % | |||||||||
December 31, 2025 | December 31, 2024 | ||||||||||
Beginning balance | $ | 2,532 | $ | 1,850 | |||||||
Increases based on tax positions related to prior periods | 995 | 490 | |||||||||
Increases based on tax positions related to current period | 326 | 192 | |||||||||
| Ending balance | $ | 3,853 | $ | 2,532 | |||||||
Tax year | |||||
United States | 2022 | ||||
California | 2021 | ||||
Netherlands | 2019 | ||||
December 31, 2025 | December 31, 2024 | ||||||||||
Deferred tax assets: | |||||||||||
Net operating loss and capital loss carryforwards | $ | 15,735 | $ | 6,638 | |||||||
Tax credits | 5,304 | 4,894 | |||||||||
Interest expense | 3,397 | 2,346 | |||||||||
Investment in partnerships | 21,764 | 24,760 | |||||||||
Other | 258 | 225 | |||||||||
Total deferred tax assets | 46,458 | 38,863 | |||||||||
Valuation allowance | (45,541) | (38,616) | |||||||||
Total net deferred tax assets | $ | 917 | $ | 247 | |||||||
Deferred tax liabilities: | |||||||||||
Intangibles | $ | (3,808) | $ | (6,026) | |||||||
Other | (1,122) | (420) | |||||||||
Total deferred tax liabilities | $ | (4,930) | $ | (6,446) | |||||||
Net deferred tax liability | $ | (4,013) | $ | (6,199) | |||||||
December 31, 2025 | December 31, 2024 | ||||||||||
Valuation allowance, at beginning of year | $ | 38,616 | $ | 22,658 | |||||||
Increases in valuation allowance recorded through earnings | 7,290 | 15,798 | |||||||||
Increases in valuation allowance not recorded through earnings | (365) | 160 | |||||||||
| Valuation allowance, at end of year | $ | 45,541 | $ | 38,616 | |||||||
For the Year Ended | |||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||
Federal taxes | $ | 47 | $ | (152) | |||||||
States taxes: | |||||||||||
California | 32 | (89) | |||||||||
Texas | (32) | 56 | |||||||||
| Other state jurisdictions | (18) | (31) | |||||||||
Foreign taxes: | |||||||||||
Canada | (770) | 615 | |||||||||
Netherlands | 698 | (1,216) | |||||||||
Other foreign jurisdictions | — | 8 | |||||||||
Total cash taxes paid | $ | (43) | $ | (809) | |||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 11, 2026 | Showing above |
| 2024 | Mar 10, 2025 | |
| 2023 | Mar 15, 2024 | |
| 2022 | Jun 6, 2023 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.